China Resources Pharmaceutical Group Limited (HKG:3320)

HKG:3320 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16,425	24,651	15,224	14,267	9,457
Short-Term Investments	-	7,581	7,507	9,766	5,822
Cash & Short-Term Investments	16,425	32,231	22,731	24,034	15,280
Cash Growth	-49.04%	41.79%	-5.42%	57.29%	-5.93%
Accounts Receivable	83,168	95,695	84,818	78,175	73,078
Other Receivables	8,177	6,912	6,845	7,612	6,197
Receivables	91,345	102,607	91,663	85,787	79,275
Inventory	37,053	31,875	26,547	24,186	20,701
Prepaid Expenses	4,070	4,797	4,953	3,506	3,149
Restricted Cash	-	-	-	10.39	-
Other Current Assets	36,954	7,057	6,366	6,356	5,466
Total Current Assets	185,846	178,568	152,259	143,879	123,871
Property, Plant & Equipment	25,907	25,043	21,698	20,398	19,066
Long-Term Investments	6,143	6,878	6,622	6,388	5,334
Goodwill	22,369	21,454	20,409	20,287	17,744
Other Intangible Assets	8,508	6,536	6,359	6,149	4,852
Long-Term Deferred Tax Assets	1,969	1,773	1,435	1,067	816.65
Long-Term Deferred Charges	-	1,481	1,206	1,184	991.78
Other Long-Term Assets	7,018	5,037	5,546	3,146	2,894
Total Assets	257,760	246,770	215,534	202,497	176,299
Accounts Payable	58,598	54,451	48,853	42,673	38,479
Accrued Expenses	4,734	4,231	5,360	4,226	3,409
Short-Term Debt	-	-	10,167	10,018	9,428
Current Portion of Long-Term Debt	44,853	45,760	35,941	38,259	33,789
Current Portion of Leases	520.27	463.53	495.95	475.61	597.81
Current Income Taxes Payable	954.9	730.03	667.3	728.63	565.12
Current Unearned Revenue	4,225	4,023	3,538	2,898	2,086
Other Current Liabilities	18,337	24,574	16,747	15,854	14,897
Total Current Liabilities	132,222	134,233	121,770	115,132	103,251
Long-Term Debt	22,864	15,092	9,042	5,850	1,691
Long-Term Leases	768.14	844.89	770.27	759.16	973.15
Long-Term Unearned Revenue	-	788.58	775.14	725.69	548.54
Long-Term Deferred Tax Liabilities	1,915	1,718	1,587	1,601	1,405
Other Long-Term Liabilities	1,130	356.96	203.29	161.17	173.77
Total Liabilities	159,673	153,795	134,977	125,116	108,911
Common Stock	24,630	24,630	24,630	22,193	22,938
Retained Earnings	-	29,705	26,731	23,134	21,373
Comprehensive Income & Other	23,614	-8,376	-7,804	-3,794	-5,181
Total Common Equity	48,244	45,960	43,557	41,533	39,129
Minority Interest	49,843	47,015	37,000	35,848	28,259
Shareholders' Equity	98,087	92,975	80,557	77,381	67,388
Total Liabilities & Equity	257,760	246,770	215,534	202,497	176,299
Total Debt	69,005	62,161	56,416	55,362	46,478
Net Cash (Debt)	-52,580	-29,930	-33,685	-31,328	-31,199
Net Cash Per Share	-8.37	-4.76	-5.36	-4.99	-4.97
Filing Date Shares Outstanding	6,283	6,283	6,283	6,283	6,283
Total Common Shares Outstanding	6,283	6,283	6,283	6,283	6,283
Working Capital	53,624	44,335	30,489	28,747	20,621
Book Value Per Share	7.68	7.32	6.93	6.61	6.23
Tangible Book Value	17,367	17,969	16,789	15,098	16,534
Tangible Book Value Per Share	2.76	2.86	2.67	2.40	2.63
Buildings	-	16,124	13,507	12,991	12,070
Machinery	-	12,511	10,556	9,366	8,353
Construction In Progress	-	1,339	1,930	972.25	533.57
Leasehold Improvements	-	960.31	741.77	660.19	587.37

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.